Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
EBRPY Stock Summary
In the News
EBRPY Financial details
Company Rating
-
Market Cap
2.75B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.21
Dividend %
1.15%
Employees
6.29K
Optionable
No
Shortable
Yes
Earnings
-
P/E
20.6
Forward P/E
-
PEG
-
P/S
0.85
P/B
1.16
P/C
-
P/FCF
24.12
Quick Ratio
0.21
Current Ratio
1.92
Debt / Equity
0.34
LT Debt / Equity
0.24
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-15.96%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-3%
Revenue last 5Y
2.29%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
3%
ROE
6%
ROC
0.07%
Gross Margin
43%
Oper. Margin
7%
Profit Margin
4%
Payout
79%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
15.0-18.05
52W High
-
52W Low
-
RSI
-
Rel Volume
10.14
Avg Volume
50
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.177099
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
EBRPY Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 17.2 | 18.28 | 18.8 | 15.75 | 19.26 | |
Net income per share | 0.92 | 0.92 | 0.92 | 0.94 | 0.79 | |
Operating cash flow per share | 1.38 | 1.63 | 2.4 | 0.11 | 1.45 | |
Free cash flow per share | 0.47 | 0.66 | 1.64 | -0.67 | 0.68 | |
Cash per share | 1.12 | 1.64 | 1.38 | 3.52 | 1.21 | |
Book value per share | 14.05 | 14.7 | 12.53 | 13.66 | 14.07 | |
Tangible book value per share | 3.88 | 3.16 | 2.9 | 5.78 | 6.25 | |
Share holders equity per share | 14.05 | 14.7 | 12.53 | 13.66 | 14.07 | |
Interest debt per share | 4.69 | 7.13 | 6.38 | 5.54 | 4.82 | |
Market cap | 2.62B | 2.92B | 2.96B | 2.64B | 2.16B | |
Enterprise value | 3.16B | 3.75B | 3.72B | 2.95B | 2.71B | |
P/E ratio | 18.51 | 20.57 | 21.05 | 18.2 | 17.72 | |
Price to sales ratio | 0.99 | 1.04 | 1.02 | 1.09 | 0.73 | |
POCF ratio | 12.38 | 11.64 | 8.01 | 151.15 | 9.7 | |
PFCF ratio | 36.01 | 28.66 | 11.75 | -25.77 | 20.75 | |
P/B Ratio | 1.21 | 1.29 | 1.54 | 1.26 | 1 | |
PTB ratio | 1.21 | 1.29 | 1.54 | 1.26 | 1 | |
EV to sales | 1.19 | 1.33 | 1.29 | 1.22 | 0.92 | |
Enterprise value over EBITDA | 10.37 | 11 | 11.17 | 9.58 | 8.16 | |
EV to operating cash flow | 14.93 | 14.97 | 10.07 | 168.78 | 12.16 | |
EV to free cash flow | 43.43 | 36.86 | 14.76 | -28.77 | 26.01 | |
Earnings yield | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | |
Free cash flow yield | 0.03 | 0.03 | 0.09 | -0.04 | 0.05 | |
Debt to equity | 0.33 | 0.48 | 0.5 | 0.4 | 0.34 | |
Debt to assets | 0.19 | 0.25 | 0.24 | 0.22 | 0.19 | |
Net debt to EBITDA | 1.77 | 2.45 | 2.28 | 1 | 1.65 | |
Current ratio | 1.55 | 1.55 | 1.13 | 1.88 | 1.92 | |
Interest coverage | 20.72 | 19.88 | 22.09 | 43.57 | 29.01 | |
Income quality | 1.5 | 0 | 0 | 0 | 1.83 | |
Dividend Yield | 0.04 | 0.03 | 0.13 | 0.07 | 0.04 | |
Payout ratio | 0.67 | 0.7 | 2.82 | 1.28 | 0.79 | |
Sales general and administrative to revenue | 0.17 | 0.16 | 0.15 | 0.16 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.42 | 0.41 | 0.37 | 0.32 | 0.32 | |
Capex to operating cash flow | -0.66 | -0.59 | -0.32 | -6.87 | -0.53 | |
Capex to revenue | -0.05 | -0.05 | -0.04 | -0.05 | -0.04 | |
Capex to depreciation | 0 | 0 | 0 | 0 | -1.18 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 17.06 | 17.46 | 16.06 | 17.03 | 15.85 | |
ROIC | 0.05 | 0.04 | 0.06 | 0.05 | 0.05 | |
Return on tangible assets | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 | |
Graham Net | -7.78 | -7.33 | -7.67 | -3.5 | -4.04 | |
Working capital | 438.89M | 494.04M | 151.02M | 809.56M | 799.31M | |
Tangible asset value | 597M | 486.49M | 446.84M | 889.48M | 961.73M | |
Net current asset value | -401.12M | -687.08M | -761.63M | -72.12M | -32.76M | |
Invested capital | 0.33 | 0.48 | 0.5 | 0.4 | 0.34 | |
Average receivables | 0 | 272.46M | 553.18M | 553.17M | 585.79M | |
Average payables | 339.96M | 345.63M | 366.81M | 365.83M | 352.73M | |
Average inventory | 527.55M | 565.46M | 557.28M | 581.61M | 740.81M | |
Days sales outstanding | 0 | 70.7 | 70.83 | 82.07 | 77.17 | |
Days payables outstanding | 86.99 | 83.26 | 87.8 | 94.34 | 77.77 | |
Days of inventory on hand | 137.85 | 140.44 | 120.15 | 173.3 | 182.99 | |
Receivables turnover | 0 | 5.16 | 5.15 | 4.45 | 4.73 | |
Payables turnover | 4.2 | 4.38 | 4.16 | 3.87 | 4.69 | |
Inventory turnover | 2.65 | 2.6 | 3.04 | 2.11 | 1.99 | |
ROE | 0.07 | 0.06 | 0.07 | 0.07 | 0.06 | |
Capex per share | -0.9 | -0.97 | -0.76 | -0.78 | -0.77 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q4
Metric | History | 2020-12-31 | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | 760.62M | 726.42M | 308.38M | 493.76M | 549.22M | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.5 | 0.54 | 0.4 | 0.33 | 0.34 | |
Debt to assets | 0.24 | 0.26 | 0.22 | 0.18 | 0.19 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 1.13 | 1.19 | 1.88 | 1.93 | 1.92 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.37 | 0.37 | 0.32 | 0.32 | 0.32 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 151.02M | 247.38M | 809.56M | 784.78M | 799.31M | |
Tangible asset value | 446.84M | 482.37M | 889.48M | 928.51M | 961.73M | |
Net current asset value | -761.63M | -607.65M | -72.12M | -59.82M | -32.76M | |
Invested capital | 0.5 | 0.54 | 0.4 | 0.33 | 0.34 | |
Average receivables | 0 | 0 | 0 | 274.09M | 587.42M | |
Average payables | 440.55M | 385.7M | 365.51M | 380.33M | 387.42M | |
Average inventory | 579.8M | 602.68M | 656.03M | 733.61M | 839.46M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
EBRPY Frequently Asked Questions
What is Ebro Foods, S.A. stock symbol ?
Ebro Foods, S.A. is a ES stock and trading under the symbol EBRPY
What is Ebro Foods, S.A. stock quote today ?
Ebro Foods, S.A. stock price is $- today.
Is Ebro Foods, S.A. stock public?
Yes, Ebro Foods, S.A. is a publicly traded company.